vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $20.6M, roughly 1.7× Entrada Therapeutics, Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -84.4%, a 82.6% gap on every dollar of revenue. On growth, Clearfield, Inc. posted the faster year-over-year revenue change (-3.2% vs -65.2%). Clearfield, Inc. produced more free cash flow last quarter ($-2.4M vs $-39.7M). Over the past eight quarters, Entrada Therapeutics, Inc.'s revenue compounded faster (6.4% CAGR vs -3.5%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
CLFD vs TRDA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $20.6M |
| Net Profit | $-614.0K | $-17.3M |
| Gross Margin | 33.2% | — |
| Operating Margin | -5.3% | -106.0% |
| Net Margin | -1.8% | -84.4% |
| Revenue YoY | -3.2% | -65.2% |
| Net Profit YoY | 67.8% | -173.8% |
| EPS (diluted) | $-0.04 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | — | ||
| Q3 25 | $23.4M | — | ||
| Q2 25 | $49.9M | — | ||
| Q1 25 | $47.2M | $20.6M | ||
| Q4 24 | $29.7M | $37.4M | ||
| Q3 24 | $5.6M | $19.6M | ||
| Q2 24 | $48.8M | $94.7M | ||
| Q1 24 | $36.9M | $59.1M |
| Q4 25 | $-614.0K | — | ||
| Q3 25 | $-9.1M | — | ||
| Q2 25 | $1.6M | — | ||
| Q1 25 | $1.3M | $-17.3M | ||
| Q4 24 | $-1.9M | $1.1M | ||
| Q3 24 | — | $-14.0M | ||
| Q2 24 | $-447.0K | $55.0M | ||
| Q1 24 | $-5.9M | $23.5M |
| Q4 25 | 33.2% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 30.5% | — | ||
| Q1 25 | 30.1% | — | ||
| Q4 24 | 29.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 21.9% | — | ||
| Q1 24 | 7.7% | — |
| Q4 25 | -5.3% | — | ||
| Q3 25 | 10.3% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | 0.6% | -106.0% | ||
| Q4 24 | -6.9% | -15.7% | ||
| Q3 24 | — | -110.7% | ||
| Q2 24 | -4.7% | 56.4% | ||
| Q1 24 | -26.4% | 35.7% |
| Q4 25 | -1.8% | — | ||
| Q3 25 | -38.8% | — | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 2.8% | -84.4% | ||
| Q4 24 | -6.4% | 3.0% | ||
| Q3 24 | — | -71.7% | ||
| Q2 24 | -0.9% | 58.1% | ||
| Q1 24 | -16.0% | 39.7% |
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $-0.65 | — | ||
| Q2 25 | $0.11 | — | ||
| Q1 25 | $0.09 | $-0.42 | ||
| Q4 24 | $-0.13 | $-0.20 | ||
| Q3 24 | — | $-0.35 | ||
| Q2 24 | $-0.04 | $1.55 | ||
| Q1 24 | $-0.40 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $249.7M | $417.3M |
| Total Assets | $268.1M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | — | ||
| Q3 25 | $106.0M | — | ||
| Q2 25 | $117.2M | — | ||
| Q1 25 | $112.0M | $67.8M | ||
| Q4 24 | $113.0M | $101.2M | ||
| Q3 24 | $129.0M | $78.0M | ||
| Q2 24 | $123.8M | $185.3M | ||
| Q1 24 | $142.9M | $68.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $249.7M | — | ||
| Q3 25 | $256.2M | — | ||
| Q2 25 | $264.5M | — | ||
| Q1 25 | $265.9M | $417.3M | ||
| Q4 24 | $267.4M | $428.7M | ||
| Q3 24 | $275.8M | $422.4M | ||
| Q2 24 | $274.6M | $429.9M | ||
| Q1 24 | $279.2M | $269.4M |
| Q4 25 | $268.1M | — | ||
| Q3 25 | $306.2M | — | ||
| Q2 25 | $314.7M | — | ||
| Q1 25 | $310.9M | $486.5M | ||
| Q4 24 | $303.2M | $526.3M | ||
| Q3 24 | $315.3M | $554.6M | ||
| Q2 24 | $318.1M | $582.0M | ||
| Q1 24 | $315.4M | $510.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $-38.5M |
| Free Cash FlowOCF − Capex | $-2.4M | $-39.7M |
| FCF MarginFCF / Revenue | -7.1% | -192.9% |
| Capex IntensityCapex / Revenue | 2.9% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $7.9M | — | ||
| Q1 25 | $3.0M | $-38.5M | ||
| Q4 24 | $7.2M | $-31.6M | ||
| Q3 24 | $22.2M | $-24.3M | ||
| Q2 24 | $4.0M | $39.8M | ||
| Q1 24 | $-5.7M | $-25.5M |
| Q4 25 | $-2.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $7.5M | — | ||
| Q1 25 | $654.0K | $-39.7M | ||
| Q4 24 | $5.1M | $-32.2M | ||
| Q3 24 | $18.2M | $-24.9M | ||
| Q2 24 | $2.8M | $38.8M | ||
| Q1 24 | $-7.7M | $-26.4M |
| Q4 25 | -7.1% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 15.1% | — | ||
| Q1 25 | 1.4% | -192.9% | ||
| Q4 24 | 17.1% | -86.2% | ||
| Q3 24 | 323.0% | -127.3% | ||
| Q2 24 | 5.8% | 41.0% | ||
| Q1 24 | -20.8% | -44.6% |
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 5.1% | 5.6% | ||
| Q4 24 | 7.0% | 1.7% | ||
| Q3 24 | 71.4% | 3.3% | ||
| Q2 24 | 2.5% | 1.1% | ||
| Q1 24 | 5.3% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
